A cost-utility analysis of lisdexamfetamine versus atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and inadequate response to methylphenidate

Authors:

Zimovetz EA, Beard SM, Hodgkins P, Bischof M, Mauskopf JA and Setyawan J.

Publication Type:

Journal Article

Publication Name:

CNS drugs


Citation:

Zimovetz EA, Beard SM, Hodgkins P, Bischof M, Mauskopf JA and Setyawan J. A cost-utility analysis of lisdexamfetamine versus atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and inadequate response to methylphenidate. CNS drugs. 2016;30(10):985-96.


Link to publication ⟶

⟵ Back to Search Results